Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Clin Pharmacol Ther. 2015 Apr 3;97(5):447–450. doi: 10.1002/cpt.91

Figure 1.

Figure 1

Dramatic therapeutic effects of molecularly targeted therapies demonstrated in serial axial chest computed tomography images. (a) Radiographic response to epidermal growth factor receptor (EGFR) inhibition in patient with EGFR mutant non-small cell lung cancer (NSCLC) after 2 mo of treatment. (b) Ongoing radiographic response to anaplastic lymphoma kinase (ALK) inhibition in patient with ALK rearranged NSCLC after 6 mo of treatment.